1
TITLE: ADJUSTMENT FOR THE IMPACT OF SUBSEQUENT THERAPIES NOT AVAILABLE IN UK ON OVERALL SURVIVAL (OS) IN CASTOR TRIAL: A SUBGROUP ANALYSIS IN SECOND-LINE (2L) PATIENTS  Full Text
AUTHORS: Van Sanden, S; Perualila, N; Diels, J; Trevor, N; Pei, H; Anjo, J;
PUBLISHED: 2018, SOURCE: VALUE IN HEALTH, VOLUME: 21
INDEXED IN: WOS